摘要
Protein tyrosine kinases(PTKs)are a class of proteins with tyrosine kinase activity that phosphorylate tyrosine residues of critical molecules in signaling pathways.Their basal function is essential for maintaining normal cell growth and differentiation.However,aberrant activation of PTKs caused by various factors can deviate cell function from the expected trajectory to an abnormal growth state,leading to carcinogenesis.Inhibiting the aberrant PTK function could inhibit tumor growth.Therefore,tyrosine kinase inhibitors(TKIs),target-specific inhibitors of PTKs,have been used in treating malignant tumors and play a significant role in targeted therapy of cancer.Currently,drug resistance is the main reason for limiting TKIs efficacy of cancer.The increasing studies indicated that tumor microenvironment,cell death resistance,tumor metabolism,epigenetic modification and abnormal metabolism of TKIs were deeply involved in tumor development and TKI resistance,besides the abnormal activation of PTK-related signaling pathways involved in gene mutations.Accordingly,it is of great significance to study the underlying mechanisms of TKIs resistance and find solutions to reverse TKIs resistance for improving TKIs efficacy of cancer.Herein,we reviewed the drug resistance mechanisms of TKIs and the potential approaches to overcome TKI resistance,aiming to provide a theoretical basis for improving the efficacy of TKIs.
